Biomarker: W002-IgE Ragweed, Western

Overview

Western ragweed-specific immunoglobulin E (IgE) measures circulating IgE antibodies directed against pollen from western ragweed (Ambrosia psilostachya). IgE is involved in immediate allergic reactions, including seasonal allergic rhinitis and asthma symptoms after pollen exposure. A detectable or elevated result indicates sensitization to western ragweed, but the concentration does not reliably predict symptom severity and does not establish clinical allergy without compatible symptoms and exposure history. The test can help identify relevant inhalant allergens and guide avoidance measures or consideration of allergen immunotherapy.

Clinical Use Cases

Evaluating suspected seasonal allergic rhinitis, allergic conjunctivitis, or asthma associated with ragweed-pollen exposure.
Identifying western ragweed as a possible allergen when symptoms occur during the late-summer or fall pollen season.
Supporting allergen selection for individualized environmental-control counseling.
Complementing skin-prick testing when skin testing is contraindicated, unreliable, unavailable, or affected by skin disease.
Supporting evaluation before allergen immunotherapy when clinical history and other allergy-test findings are consistent.
Investigating possible cross-reactivity among ragweed and related weed pollens, recognizing that a positive result may reflect sensitization rather than clinically relevant allergy.

Specimen Types

Venous blood, typically collected as serum.
Plasma may be accepted by some assay systems, according to the testing laboratory’s requirements.

Measurement Methods

Automated quantitative serum allergen-specific IgE immunoassays.
Fluorescent enzyme immunoassay.
Enzyme-linked immunosorbent assay.
Chemiluminescent immunoassay.
Older radioallergosorbent testing methods, commonly referred to as RAST.

Test Preparation and Influencing Factors

Fasting is generally not required for serum-specific IgE testing.
Patients should report all medications and supplements to the ordering clinician.
Antihistamines generally do not suppress the laboratory measurement of serum-specific IgE, although they can affect skin-prick testing.
Medication changes should be made only when directed by a healthcare professional.
Collection timing usually does not require alignment with the ragweed pollen season, because the test measures circulating sensitization rather than an immediate response during exposure.
Recent or current pollen exposure may help explain symptoms but does not by itself determine the serum IgE result.
Total IgE, age, atopic conditions, smoking, parasitic infection, and other clinical factors may influence interpretation of allergy-testing results.
A positive result indicates sensitization and must be interpreted with symptoms, exposure history, physical findings, and, when appropriate, skin testing or supervised challenge.
Assay reference ranges and positivity thresholds vary by method. Results near the reporting threshold require clinical interpretation rather than automatic diagnosis.